Kenz Lotion contains Ketoconazole 2% w/v, an antifungal agent belonging to the imidazole class, indicated for the treatment of various superficial fungal infections of the skin. Ketoconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Kenz Lotion is primarily used in the management of conditions such as tinea corporis, tinea cruris, tinea pedis, and seborrheic dermatitis. The topical formulation allows for targeted therapy with minimal systemic absorption, reducing the risk of systemic side effects. Application involves cleansing the affected area and applying a thin layer of the lotion once or twice daily, as directed by a healthcare professional, for a duration typically ranging from two to four weeks depending on the severity and type of infection. Patients should avoid contact with eyes and mucous membranes and discontinue use if irritation or hypersensitivity reactions occur. Kenz Lotion is contraindicated in individuals with known hypersensitivity to ketoconazole or any of the formulation excipients. Use during pregnancy and lactation should be under medical supervision. Proper adherence to the prescribed regimen ensures optimal therapeutic outcomes and minimizes the risk of recurrence.